首页>
外国专利>
PHARMACEUTICAL COMPOSITION CONTAINING SULGLYCOTIDE OR PHARMACEUTICALLY ACCEPTABLE SALT FOR PREVENTING OR TREATING DRY EYES SYNDROME
PHARMACEUTICAL COMPOSITION CONTAINING SULGLYCOTIDE OR PHARMACEUTICALLY ACCEPTABLE SALT FOR PREVENTING OR TREATING DRY EYES SYNDROME
展开▼
机译:包含硫酸盐或药学上可接受的盐的药物组合物,用于预防或治疗干眼综合征
展开▼
页面导航
摘要
著录项
相似文献
摘要
FIELD: medicine.;SUBSTANCE: invention refers to medicine, namely to ophthalmology, and aims at preventing or treating dry eye syndrome. For prevention or treatment of dry eye syndrome, a pharmaceutical composition containing sulglycotide or its pharmaceutically acceptable salt as an active ingredient is used. Said composition has a dosage form for instillation into eyes.;EFFECT: using the invention enables considerably increasing the tear production, improving the corneal surface irregularities, increasing the density of the conjunctival beaker-shaped cells and reducing the inflammatory cytokines on the eye surface and the lachrymal gland.;7 cl, 2 tbl, 6 dwg, 15 ex
展开▼
机译:技术领域本发明涉及医学,即眼科,旨在预防或治疗干眼症。为了预防或治疗干眼症,使用了包含舒糖肽或其药学上可接受的盐作为活性成分的药物组合物。所述组合物具有用于滴入眼睛的剂型。效果:使用本发明能够显着增加泪液的产生,改善角膜表面的不规则性,增加结膜烧杯状细胞的密度并减少在眼睛表面上的炎性细胞因子。泪腺。; 7 cl,2 tbl,6 dwg,15 ex
展开▼